If you can’t see the email correctly, try viewing it in your browser
         
  The Independent Research Enabler
           
     

6th edition of TI Pharma Spring Meeting: all about Inspiring Healthy Partnerships!

Healthy multidisciplinary partnerships have the potential to create necessary solutions for global health challenges. TI Pharma continues to enable excellent pharmaceutical research in the current open innovation environment. At the Spring Meeting a few examples of newly formed international partnerships in the field of drug discovery and development were presented. These partnerships are able to address scientific challenges which would not be achievable for a single organization.

This year's event was a great success and hosted a good mix of more than 250 attendees from academia, industry, patient organizations, healthcare foundations and policy makers.

The theme 'Inspiring Healthy Partnerships' outlined the opportunities for successful multi-disciplinary collaborations to effectively address challenges in drug discovery, development and utilization.

Plenary speakers included Prof. Stan van Boeckel (Pivot Park Screening Centre) and Jutta Reinhard-Rupp (Merck Serono). Both presented cases of recent TI Pharma-enabled international partnerships.

Inspiring parallel sessions provided information on the latest developments and new insights in research projects as well as on multidisciplinary topics such as the role of health foundations in public-private partnerships.

A TI Pharma Poster Prize worth € 2,000 was awarded to two young researchers who presented research posters resulting from TI Pharma-managed partnerships.

This annual TI Pharma Spring Meeting offered a unique opportunity for exchange of knowledge and provided the latest insights in the area of drug discovery and development. Stay abreast of the latest developments and benefit from TI Pharma's valuable network by joining our next spring meeting on April 15th, 2014. Save the date!

Click here for Spring Meeting 2013 pictures.

Some of the highlights and concluding comments from sessions:


"The state of the art HTS robotics of Pivot Park Screening Centre are key in finding novel hits in early drug discovery."
Stan van Boeckel, CSO Pivot Park Oss

"It is not the disease that is neglected but the people. Schistosomiasis has a severe impact on the overall health of children in the developing world. This problem can only be addressed when partners with specific tasks and expertise collaborate successfully."
Jutta Reinhard-Rupp, Head of Access to Health R&D & Partnerships, Merck Serono

"More and more Health Foundations play an active role in public-private partnerships. They are essential for us to be able to focus on translating the best science into viable clinical concepts that will bring solutions for patients."
Tom Oostrom, Chair Dutch Partnership of Health Foundations, Director Dutch Kidney Foundation and Wia Timmerman, Project Leader Translation Research, Dutch Cancer Society



"Organizations must utilize the resources and talents of committed people at all levels of the organization. If organizations are to continue to grow and develop, leadership, decision- making and problem solving must be placed in the hands of skilled teams."
Rob Kieboom, Trainer, Rob Kieboom Training & Consultancy



"A tool that incorporates multiple risk factors to establish drug efficacy could be a useful product for regulators, drug developers and clinicians."
Hiddo Lambers Heerspink, Clinical Pharmacologist, University Medical Center Groningen



"Risk analysis is essential for clinical trial design for innovative medical products with a complex working mechanism. The workshop considered a structured approach toward describing the potential risks and the importance of countermeasures for the translation of preclinical data into a first-in-man clinical trial."
Marcel Kenter, Director Life Sciences Academy

Do you want to stay informed on our activities? Register for our newsletter!

www.tipharma.com


New! Year in Review 2013 magazine lists recent achievements in the Dutch Life Sciences & Health sector

The Dutch Life Sciences and Health sector is one of the most concentrated high performing clusters in the world. The combination of a strategic location within Europe, strong collaboration between world-class universities, industry and government, and a highly educated multilingual workforce offers the necessary climate for growth.

The Netherlands is leading a trend towards forming international public-private research and development collaborations. These partnerships cover vast areas ranging from diagnostics and medical devices to (bio)pharmaceuticals and hospital design.

Learn more about the Dutch Life Sciences & Health cluster in the Year in Review magazine 2013.


TI Pharma fellow Saskia Overbeek nominated to participate in the Eureka 5th Annual International Certificate Program in Translational Medicine

Identifying talent has always been part of the TI Pharma strategy. Stimulating and promoting our fellows in their future professional career is a continuous objective.

This year, TI Pharma fellow Saskia Overbeek was selected from the TI Pharma talent program to participate in the Eureka 5th Annual International Certificate Program in Translational Medicine which will take place from May 5th - 11th in Syracuse, Italy. Saskia is currently working on the TI Pharma project "Synergistic effects of TLR ligands and oligosaccharides".

At this Eureka course, students will acquire skills that will help them address the existing challenges in drug development today and bridge the gap between concepts and patients.


Enroll for the TI Pharma workshop 'Animal-free safety testing of new medicines' - Thursday, May 23rd, 2013 - Centraal Museum Utrecht

Gain new insights into the future of drug development without the use of animals for safety testing. Is it possible to transition towards such a situation?

Learn about the recently obtained results from the TI Pharma project on the predictive value of animal testing in pharmaceuticals and how this had led to new scientific insights.

The program includes lectures from scientists of the University of Utrecht and Nefarma, and a panel discussion with experts from industry, the regulatory authorities and academia.

For a full description of the workshop and registration procedure, please click here.


Registration for FIGON Dutch Medicines Days 2013 is open!

Meet partners involved in drug research, exchange knowledge and share new scientific insights at this year's FIGON Dutch Medicine Days. The meeting will be held from September 30th to October 2nd in venue De Reehorst in Ede.

Deadline for early registration is August 1st. Don't miss it!

For more conference details, information on how to register and on abstract submissions click here.